Companies: 49,246 Total Market Cap: 132387819536209.04

Beacon Pharmaceuticals PLC

DSE-BEACONPHAR
Pharmaceutical Preparations
Rank #20135
Market Cap 187.83 M
Volume 44,081
Price 0.80
Change (%) 1.31%
Country or region Bangladesh Bangladesh

Beacon Pharmaceuticals PLC's latest marketcap:

187.83 M

As of 05/20/2025, Beacon Pharmaceuticals PLC's market capitalization has reached $187.83 M. According to our data, Beacon Pharmaceuticals PLC is the 20135th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 187.83 M
Revenue (ttm) 94.05 M
Net Income (ttm) 4.63 M
Shares Out 231 M
EPS (ttm) 0.02
Forward PE 0.00
Ex-Dividend Date 10/28/2024
Earnings Date 04/30/2025
Market Cap Chart
Data Updated: 05/20/2025

Beacon Pharmaceuticals PLC's yearly market capitalization.

Beacon Pharmaceuticals PLC has seen its market value grow from 18.11 B BDT to 23.12 B BDT since 2020, representing a total increase of 27.68% and an annual compound growth rate (CAGR) of 5.73%.
Date Market Cap(BDT) Change (%)
05/20/2025 23.12 B -31.42%
12/30/2024 31.39 B -44.53%
12/28/2023 56.60 B -14.34%
12/29/2022 66.07 B 17.5%
12/30/2021 56.23 B 210.46%
12/30/2020 18.11 B

Company Profile

About Beacon Pharmaceuticals PLC

Beacon Pharmaceuticals PLC is a leading pharmaceutical company specializing in the production and promotion of high-quality healthcare products. Established in 2001 and headquartered in Dhaka, Bangladesh, the company operates both domestically and internationally.

Product Portfolio

The company offers a diverse range of pharmaceutical solutions, including:

  • Finished Formulations – Comprehensive drug formulations for various therapeutic needs.
  • Lifesaving Intravenous Fluids – Critical care solutions for medical emergencies.
  • Active Pharmaceutical Ingredients (APIs) – High-quality raw materials for drug manufacturing.
  • Bio-Tech & Genetic Engineering Products – Innovative treatments leveraging advanced biotechnology.

Therapeutic Categories

Beacon Pharmaceuticals serves multiple medical fields, including:

  • Oncology & Hematology
  • Hepatology & Nephrology
  • Antibiotics & Analgesics
  • Anti-Diabetics & Respiratory Care
  • Cardiovascular & Dermatology
  • Gastrointestinal & Infectious Diseases
  • Immunology & Rheumatology
  • Pediatrics & Nutritional Supplements

Contract & Toll Manufacturing

In addition to its branded products, the company provides contract and toll manufacturing services to support pharmaceutical production needs.

Brand Portfolio

Beacon Pharmaceuticals markets its products under well-known brand names such as:

  • Pemro, Nivomab, Xelpac Premium
  • Docexan, Xaloplat Aqua, Gemoxen Aqua
  • ETP, FXR, Renesis, Mezest
  • Eposis, Tirza, Xelmet, Xerova
  • Sinjard, Ovocal, Haxinor, Tetrazin
  • Lubilux, Paloxi, Olonex, Bukof
Frequently Asked Questions

As of 05/20/2025, Beacon Pharmaceuticals PLC (including the parent company, if applicable) has an estimated market capitalization of $187.83 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Beacon Pharmaceuticals PLC global market capitalization ranking is approximately 20135 as of 05/20/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region Bangladesh
Founded 2001
IPO Date n/a
Employees 4,162
CEO Mohammad Karim
Sector
Industry Pharmaceutical Preparations
Address Beacon Business Centre
Dhaka, 1223
Bangladesh
Website https://www.beaconmedicare.com.bd